From prevention to cure, repurposing anti-viral vaccines for cancer immunotherapy
Biotarget
.
2018 Dec:2:20.
doi: 10.21037/biotarget.2018.12.03.
Authors
Ons Mamai
#
1
,
Eswari Dodagatta-Marri
#
1
,
Rosemary J Akhurst
1
Affiliation
1
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
#
Contributed equally.
PMID:
30906919
PMCID:
PMC6428074
DOI:
10.21037/biotarget.2018.12.03
No abstract available
Publication types
Comment
Grants and funding
P30 CA082103/CA/NCI NIH HHS/United States
R01 CA210561/CA/NCI NIH HHS/United States
R01 HL122869/HL/NHLBI NIH HHS/United States